Emerald Therapeutics closes latest funding round
Menlo Park, California-based biotechnology company Emerald Therapeutics has closed its latest round of funding, raising the company’s total financing to $13.5 million. Founders Fund and Max Levchin, a PayPal co-founder, led the round along with investment from Schooner Capital.
2 July 2014•4 mins read
